Dr. Hannan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd
Atlanta, GA 30322Phone+1 404-441-3167
Education & Training
- Emory University School of MedicineResidency, Internal Medicine, 2013 - 2016
- Georgetown University School of MedicineClass of 2013
Certifications & Licensure
- GA State Medical License 2023 - 2026
- WA State Medical License 2016 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1450 citationsBody-Mass Index and Mortality among 1.46 Million White AdultsAmy Berrington de Gonzalez, Patricia Hartge, James R. Cerhan, Alan J. Flint, Lindsay M. Hannan
The New England Journal of Medicine. 2010-12-02 - 332 citationsLung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies.Michael J. Thun, Lindsay M. Hannan, Lucile L. Adams-Campbell, Paolo Boffetta, Julie E. Buring
Plos Medicine. 2008-09-09 - 193 citationsActive Smoking and Breast Cancer Risk: Original Cohort Data and Meta-AnalysisMia M. Gaudet, Susan M. Gapstur, Juzhong Sun, W. Ryan Diver, Lindsay M. Hannan
Journal of the National Cancer Institute. 2013-04-17
Lectures
- Clinical predictors of progression of a hepatic lesion from Li-RADS (LR) 3 to LR5 among patients (pts) at risk of hepatocellular carcinoma (HCC).ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Clinical predictors of radiographic progression of a hepatic lesion from Li-RADS 3 to Li-RADS 5 among a population of individuals at high risk of hepatocellular carcin...2019 ASCO Annual Meeting - 6/1/2019
- A retrospective analysis of clinical outcomes among patients with infiltrative hepatocellular carcinoma (iHCC): A single institution study.2019 ASCO Annual Meeting - 6/1/2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: